Viewing Study NCT03445650


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-27 @ 5:59 AM
Study NCT ID: NCT03445650
Status: COMPLETED
Last Update Posted: 2023-02-09
First Post: 2018-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
Sponsor: Aldeyra Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ADX-102-SLS-006
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators